核心观点 - 福陆公司因涉嫌在2025年2月18日至7月31日期间对重大成本问题和财务影响作出虚假或误导性陈述被提起集体诉讼 导致股价单日暴跌超27% [1][3][4] 财务表现 - 2025年第二季度非GAAP每股收益0.43美元 较市场预期低0.13美元 [4] - 季度营收39.8亿美元 同比下降5.9% 较市场预期低5.7亿美元 [4] - 公司下调2025财年财务指引 归因于客户资本开支削减及经济不确定性导致的签约延迟 [4] 项目风险 - 戈迪·豪国际大桥 I-635/LBJ和I-35高速公路项目因分包商设计错误 价格上涨和进度延误导致成本超支 [3][4] - 经济不确定性导致客户推迟新项目授予 对业务增长产生负面影响 [3][4] 市场反应 - 2025年8月1日披露财报及项目问题后 公司股价单日跌幅超过27% [4] - 诉讼指控公司风险缓释策略的有效性被夸大 且低估了经济不确定性对财务的实际影响 [3][4] 公司业务 - 主要从事工程采购和施工 模块化制造以及项目管理服务 [2] - 基础设施项目包括加拿大边境桥梁和德克萨斯州多条高速公路工程 [2]

Accessibility StatementSkip Navigation NEW YORK, Sept. 16, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Fluor Corporation (NYSE: FLR) between February 18, 2025 and July 31, 2025, both dates inclusive (the "Class Period"). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than November 14, 2025. So what: If you purchase ...

Accessibility StatementSkip Navigation PHILADELPHIA, Sept. 16, 2025 /PRNewswire/ -- Berger Montague PC, national plaintiffs' law firm, announces a class action lawsuit against LifeMD, Inc. (NASDAQ: LFMD) ("LifeMD" or the "Company") on behalf of investors who purchased or acquired shares during the period from May 7, 2025 through August 5, 2025(the "Class Period"). Investor Deadline: Investors who purchased or acquired LifeMD securities during the Class Period may, no later than October 27, 2025, seek to b ...

诉讼背景 - Levi & Korsinsky律所通知Alto Neuroscience Inc（NYSE: ANRO）投资者涉及证券集体诉讼[1] - 诉讼旨在为因涉嫌证券欺诈而遭受损失的投资者挽回损失[2] 集体范围 - 集体包括2024年2月2日左右根据公司IPO发行文件购买或收购Alto普通股的个人和实体[2] - 集体还包括在2024年2月2日至2024年10月22日期间（含首尾两日）购买或收购Alto证券的所有人员[2] 指控内容 - 公司产品管线ALTO-100治疗重度抑郁症的疗效低于管理层向投资者传达的水平[3] - ALTO-100的临床、监管和商业前景被夸大[3] - 公司业务和/或财务前景因此被高估[3] - 公司公开声明在相关时间存在重大虚假和误导性[3] 程序信息 - 受影响投资者可在2025年9月19日前向法院申请担任首席原告[4] - 集体成员可能无需支付自付费用即可获得补偿[4]

NEW YORK, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Savara Inc. ("Savara Inc." or the "Company") (NASDAQ: SVRA) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Savara Inc. investors who were adversely affected by alleged securities fraud between March 4, 2024 and May 23, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/savara-inc-lawsuit-submissio ...

诉讼核心信息 - 特斯拉公司面临集体诉讼 指控其在2023年4月19日至2025年6月22日期间涉嫌证券欺诈 [1] - 诉讼代表在此期间遭受损失的投资者寻求赔偿 [1] 指控具体内容 - 公司被指控夸大自动驾驶技术有效性 [2] - 存在Robotaxi等自动驾驶车辆危险驾驶或违反交通法规的重大风险 [2] - 上述情况导致公司面临更强监管审查的可能性增加 [2] - 公司业务和财务前景被夸大 公开声明存在重大虚假和误导性内容 [2] 诉讼程序安排 - 投资者申请担任首席原告的截止日期为2025年10月3日 [2] - 参与集体诉讼成员无需支付任何自付费用 [3] 律所背景 - Levi & Korsinsky律所过去20年为受损股东追回数亿美元资金 [4] - 拥有70多名员工的专业团队 连续七年入选美国证券诉讼前50强律所 [4]

NEW YORK, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Replimune Group, Inc. ("Replimune Group, Inc." or the "Company") (NASDAQ: REPL) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Replimune Group, Inc. investors who were adversely affected by alleged securities fraud between November 22, 2024 and July 21, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/p ...

集体诉讼案件背景 - 律师事务所Levi & Korsinsky代表在2024年7月24日至2025年7月22日期间因证券欺诈遭受损失的Fiserv投资者提起集体诉讼 [1] - 投资者需在2025年9月22日前申请作为首席原告 参与诉讼无需支付任何额外成本或费用 [3] 涉嫌证券欺诈的具体指控 - 公司因成本问题强制Payeezy商户迁移至Clover平台 暂时性提升Clover收入增长和总支付量(GPV)增长 [2] - 迁移后大量原Payeezy商户因Clover定价过高 客户服务不足等问题转向竞争对手解决方案 [2] - 商户流失导致Clover的GPV增长显著放缓 收入增长不可持续 [2] - 公司关于Clover增长策略 竞争地位 流失率 GPV增长和业务前景的正面陈述存在重大虚假性和误导性 [2] 律师事务所资质说明 - Levi & Korsinsky过去20年为受损股东追回数亿美元资金 拥有70多名员工的专业团队 [4] - 连续七年被ISS证券集体诉讼服务评为美国顶级证券诉讼律师事务所之一 [4]

NEW YORK, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Unicycive Therapeutics, Inc. ("Unicycive Therapeutics, Inc." or the "Company") (NASDAQ: UNCY) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Unicycive Therapeutics, Inc. investors who were adversely affected by alleged securities fraud between March 29, 2024 and June 27, 2025. Follow the link below to get more information and be contacted by a member of our team: ...

NEW YORK, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Lockheed Martin Corporation ("Lockheed Martin Corporation" or the "Company") (NYSE: LMT) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Lockheed Martin Corporation investors who were adversely affected by alleged securities fraud between January 23, 2024 and July 21, 2025. Follow the link below to get more information and be contacted by a member of our team: htt ...